跳到正文

Fairmount Healthcare Fund II L.P. 内部人交易：近期 SEC Form 4 交易

过去 18 个月，Fairmount Healthcare Fund II L.P.（CIK 1769651）在 8 家公司共报告 22 笔 SEC Form 4 内部人交易（最近一笔 2026-09-03）。

日期公司身份类型股数市值
2026-09-03Apogee Therapeutics, Inc. (APGE)董事卖出340,855$0
2026-09-03Apogee Therapeutics, Inc. (APGE)董事卖出51,166$0
2026-09-03Apogee Therapeutics, Inc. (APGE)董事卖出51,166$0
2026-08-11Apogee Therapeutics, Inc. (APGE)董事买入31,838$541,246
2026-08-11Apogee Therapeutics, Inc. (APGE)董事买入10,370$454,724
2026-07-20CRESCENT BIOPHARMA, INC. (CBIO)董事买入853,450$12.4M
2026-07-01Oruka Therapeutics, Inc. (ORKA)董事买入3.6M$0
2026-07-01Oruka Therapeutics, Inc. (ORKA)董事卖出3.6M$300.0M
2026-06-23Spyre Therapeutics, Inc. (SYRE)董事买入666,680$0
2026-06-23Spyre Therapeutics, Inc. (SYRE)董事卖出4.7M$399.7M
2026-05-13Viridian Therapeutics, Inc.DE (VRDN)董事买入1.2M$20.0M
2026-04-01Zenas BioPharma, Inc. (ZBIO)董事买入150,000$3.0M
2026-02-12Galecto, Inc. (GLTO)10% 以上股东买入5.8M$0
2026-02-12Galecto, Inc. (GLTO)10% 以上股东买入2.9M$0
2026-01-22Apogee Therapeutics, Inc. (APGE)董事卖出1.8M$133.5M
2025-12-08CRESCENT BIOPHARMA, INC. (CBIO)董事买入1.4M$18.2M
2025-10-27Viridian Therapeutics, Inc.DE (VRDN)董事买入454,545$10.0M
2025-10-09Zenas BioPharma, Inc. (ZBIO)董事买入316,219$6.0M
2025-10-08Jade Biosciences, Inc. (JBIO)董事买入1.3M$12.2M
2025-09-19Oruka Therapeutics, Inc. (ORKA)董事买入333,340$5.0M
2025-06-11Viridian Therapeutics, Inc.DE (VRDN)董事买入1,600$12,480
2025-06-11Viridian Therapeutics, Inc.DE (VRDN)董事买入12,500$153,875

来源：SEC Form 4 申报文件 · 截至 2026-09-03